WTIM
ZBH icon

Wilmington Trust Investment Management’s Zimmer Biomet ZBH Stock Holding History

Wilmington Trust Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,577
Closed -$237K – 403
2014
Q1 		$237K Sell
2,577
-824
-24% -$75.9K 0.05% 330
2013
Q4 		$308K Hold
3,401
– – 0.06% 272
2013
Q3 		$271K Hold
3,401
– – 0.06% 303
2013
Q2 		$247K Buy
+3,401
New +$254K 0.05% 349

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Wilmington Trust Investment Management's ZBH Position: Q2 2014 in Review

Wilmington Trust Investment Management sold out of Zimmer Biomet (ZBH) in Q2 2014, closing a stake of 2,577 shares — an estimated $237K sold.

Wilmington Trust Investment Management first reported a position in ZBH in Q2 2013 and held it in 4 quarters. The position peaked at $308K in Q4 2013. 707 funds tracked by Wall St. Rank hold ZBH as of Q2 2014.

  • Wilmington Trust Investment Management reported no remaining Zimmer Biomet position as of Q2 2014 after selling out during the quarter.
  • Wilmington Trust Investment Management sold 2,577 Zimmer Biomet shares in Q2 2014, an estimated $237K.
  • Wilmington Trust Investment Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 4 quarters.
  • Wilmington Trust Investment Management's Zimmer Biomet position peaked at $308K in Q4 2013.
  • 707 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.